NCT02521116View on ClinicalTrials.gov

Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

January 3, 2017

Study Completion Date

February 28, 2018

Conditions
Healthy SubjectsDiabetic RetinopathyRetinal Vein Occlusion
Interventions
OTHER

Dynamic Vessel Analyzer

OTHER

Oxymap T1

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT02521116 - Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap | Biotech Hunter | Biotech Hunter